{"id":"W4327932052","doi":"10.1055/s-0042-1760567","title":"Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec (CSL222) vs. extended half-life Factor IX therapies for severe or moderately severe hemophilia B","year":2023,"lang":"en","type":"article","venue":"Hämostaseologie","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Factor IX; Haemophilia; Haemophilia B; Genetic enhancement; Clinical trial; Internal medicine; Surgery; Haemophilia A; Gene; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002838205,0.0005190431,0.001003342,0.000227854,0.0004043022,0.00003477813,0.0003693519,0.0003136788,0.0005930507],"category_scores_gemma":[0.0002618478,0.0002631388,0.0005085347,0.0007997481,0.0003496485,0.00008098439,0.0001045435,0.0002372996,0.00007281388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002684717,"about_ca_system_score_gemma":0.001082064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001635144,"about_ca_topic_score_gemma":0.000145968,"domain_scores_codex":[0.9971418,0.0002210524,0.0005431203,0.0006316743,0.0005841212,0.0008782717],"domain_scores_gemma":[0.9976587,0.0007539716,0.0001723518,0.0008935535,0.0002363746,0.0002849939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.07466245,0.01021605,0.3071406,0.00137249,0.01580902,0.001291576,0.01165716,0.001242116,0.1294965,0.0005088247,0.1158157,0.3307875],"study_design_scores_gemma":[0.02853924,0.008385701,0.2908079,0.0002135176,0.0005430118,0.000216099,0.001829805,0.003137761,0.6057563,0.0008935846,0.0585507,0.00112635],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818839,0.002574061,0.00004589894,0.01028116,0.0002658312,0.00315176,0.001213134,0.0002815005,0.0003027673],"genre_scores_gemma":[0.9840652,0.004884345,0.0009734944,0.0005159993,0.0001576173,0.0003970098,0.0004219196,0.00007876137,0.008505646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4762598,"threshold_uncertainty_score":0.9999821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1893468952219408,"score_gpt":0.3743744757300747,"score_spread":0.1850275805081339,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}